Loading...
Apogee Therapeutics, Inc.
APGE•NASDAQ
Healthcare
Biotechnology
$37.60
$-3.22(-7.89%)
Apogee Therapeutics, Inc. (APGE) Financial Performance & Income Statement Overview
Review Apogee Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-133.19%
↓ 133.19%
Net Income Growth
100.00%
↑ 100.00%
Operating Cash Flow Growth
-128.96%
↓ 128.96%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-18.74%
↓ 18.74%
ROIC
-35.49%
↓ 35.49%
Apogee Therapeutics, Inc. (APGE) Income Statement & Financial Overview
Review Apogee Therapeutics, Inc.'s (APGE) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $36000.00 | $29000.00 |
| Gross Profit | $0.00 | $0.00 | -$36000.00 | -$29000.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $60.23M | $45.71M | $33.21M | $28.72M |
| SG&A Expenses | $15.65M | $12.97M | $10.92M | $9.44M |
| Operating Expenses | $75.88M | $58.69M | $44.12M | $38.15M |
| Total Costs & Expenses | $75.88M | $58.69M | $44.12M | $38.18M |
| Interest Income | $8.68M | $9.67M | $10.31M | $6.09M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $76000.00 | $48000.00 | $36000.00 | $29000.00 |
| EBITDA | -$75.81M | -$58.64M | -$44.09M | -$38.15M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$75.88M | -$58.69M | -$44.12M | -$38.18M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $8.68M | $9.67M | $10.31M | $6.09M |
| Income Before Tax | -$67.20M | -$49.02M | -$33.82M | -$32.09M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $18000.00 | $0.00 | $0.00 | -$14276.00 |
| Net Income | -$67.22M | -$49.02M | -$33.82M | -$32.09M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$1.22 | -$0.86 | -$0.60 | -$0.64 |
| Diluted EPS | -$1.22 | -$0.86 | -$0.60 | -$0.64 |
| Weighted Avg Shares Outstanding | $55.19M | $56.80M | $56.52M | $50.19M |
| Weighted Avg Shares Outstanding (Diluted) | $55.19M | $56.80M | $56.52M | $50.19M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan